Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trials.
Lou Shenghan, Lv Houchen, Chen Yuxiang, +2 more·BMJ open
INTRODUCTION: The existing medications approved for treatment of primary osteoporosis can be divided into antiresorptive drugs and anabolic drugs. According to the mechanisms of action, the combined therapy may produce a synergistic effect on bone mineral density (BMD) compared with monotherapy, and thus improves the e…